1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-12-01
|
Series: | Lupus Science and Medicine |
_version_ | 1811292611488514048 |
---|---|
author | Karen Costenbader Yuqing Zhang Hyon Choi April Jorge Emma Materne Baijun Zhou |
author_facet | Karen Costenbader Yuqing Zhang Hyon Choi April Jorge Emma Materne Baijun Zhou |
author_sort | Karen Costenbader |
collection | DOAJ |
first_indexed | 2024-04-13T04:48:57Z |
format | Article |
id | doaj.art-95e1136c532b4974af19e596870568fe |
institution | Directory Open Access Journal |
issn | 2053-8790 |
language | English |
last_indexed | 2024-04-13T04:48:57Z |
publishDate | 2022-12-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Lupus Science and Medicine |
spelling | doaj.art-95e1136c532b4974af19e596870568fe2022-12-22T03:01:46ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-12-019Suppl 310.1136/lupus-2022-lupus21century.991604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus ErythematosusKaren Costenbader0Yuqing Zhang1Hyon Choi2April Jorge3Emma Materne4Baijun Zhou5Medicine, Brigham and Women`s Hospital, Boston, Massachusetts, USA2 Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA7 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital3Department of Medicine, Massachusetts General Hospital1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital |
spellingShingle | Karen Costenbader Yuqing Zhang Hyon Choi April Jorge Emma Materne Baijun Zhou 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus Lupus Science and Medicine |
title | 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus |
title_full | 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus |
title_fullStr | 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus |
title_full_unstemmed | 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus |
title_short | 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus |
title_sort | 1604 comparative risks of infection with belimumab versus oral immunosuppressants in patients with non renal systemic lupus erythematosus |
work_keys_str_mv | AT karencostenbader 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus AT yuqingzhang 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus AT hyonchoi 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus AT apriljorge 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus AT emmamaterne 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus AT baijunzhou 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus |